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Abstract
Background: Rapid identification (ID) and antibiotic susceptibility testing (AST) of the causative micro-organism of
bloodstream infections result in earlier targeting of antibiotic therapy.
In order to obtain results of ID and AST up to 24 hours earlier, we evaluated the accuracy of direct inoculation of
the Phoenix system from positive blood cultures (BACTEC) by using Serum Separator Tubes to harvest bacteria
from positive blood cultures. Results were compared to those of standard Phoenix procedure. Discrepancies
between the two methods were resolved by using the API system, E-test or microbroth dilution.
Results: ID with the direct method was correct for 95.2% of all tested Enterobacteriaceae (n = 42) and 71.4% of
Pseudomonas aeruginosa strains (n = 7).
AST with the direct method showed a categorical agreement for Gram-negative rods (GNR) of 99.0%, with 0.7%
minor errors, 0.3% very major errors and no major errors. All antibiotics showed an agreement of >95%.
The direct method for AST of Staphylococcus (n = 81) and Enterococcus (n = 3) species showed a categorical
agreement of 95.4%, with a minor error rate of 1.1%, a major error rate of 3.1% and a very major error rate of 0.4%.
All antibiotics showed an agreement of >90%, except for trimethoprim-sulfamethoxazole and erythromycin.
Conclusions: Inoculation of Phoenix panels directly from positive blood cultures can be used to report reliable
results of AST of GNR a day earlier, as well as ID-results of Enterobacteriaceae. For Staphylococcus and Enterococcus
species, results of AST can also be reported a day earlier for all antibiotics, except for erythromycin and
trimethoprim-sulfamethoxazole.
Background
Bloodstream infections are a common condition, affect-
ing approximately 2% of all hospitalised patients and up
to 70% of all patients in the Intensive Care Unit, and
the incidence is rising [1-4]. Mortality is high, ranging
from 14 to 57% [5]. In this group of patients, rapid iden-
tification (ID) and antibiotic susceptibility testing (AST)
of the causative microorganism are essential since they
result in earlier targeting of antibiotic therapy [6-9].
Early administration of adequate antibiotic therapy has
been shown to reduce mortality [10-12].
The introduction of automated blood culture systems
and automated systems for ID and AST have reduced
the time to diagnosis in bloodstream infections. How-
ever, for these systems, blood cultures have to be sub-
cultured on agar before ID and AST can be performed,
which can take up to 24 hours.
An alternative for subculture on agar is harvesting the
bacteria needed for inoculation of these systems directly
from positive blood cultures by using Serum Separator
Tubes, thereby reducing the time needed to obtain
results of ID and AST by a day. Although this method
has been successfully tested for many automated sys-
tems [13-17], direct inoculation was reported only twice
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for the BD Phoenix Automated Microbiology System
(BD), once for Gram-negative rods (GNR) [18] and once
for Gram-positive cocci (GPC) [19]. Both studies com-
pared their results of the direct method with results of
the Vitek system.
No studies are available comparing results of direct
inoculation with the routinely used method of inoculat-
ing the Phoenix system, which is the standard procedure
for ID and AST in many microbial diagnostic labora-
tories. Here, we evaluated the accuracy of direct inocula-
tion of the Phoenix system with positive blood culture
isolates, compared to the routinely used procedure.
Methods
Sample collection
Between January and April 2009, blood cultures grown
in the previous 24 hours in the Bactec automated blood
culture device (Bactec™ 9240, BD Diagnostic Systems,
Sparks, MD, USA) and containing Staphylococcus spe-
cies, Enterococcus species or obligate aerobic and facul-
tative anaerobic GNR were evaluated. Polymicrobial
cultures as well as cultures containing anaerobes or
fungi were excluded from the analysis. Streptococcus
spp. are not routinely processed in the Phoenix system
in our lab and were therefore also excluded from the
analysis. One positive blood culture per patient per epi-
sode of bloodstream infection was included in the study.
The study was performed in the Department of Medical
Microbiology of the Maastricht University Medical Cen-
ter (MUMC), a 750-bed referral hospital.
All samples were used according to the code for
proper use of human tissue as formulated by the Dutch
Federation of Medical Scientific Societies.
Blood cultures
Blood drawn from patients admitted in the MUMC and
suspected for bloodstream infection was incubated in
blood culture bottles (Plus+Aerobic (product no.
442192; BD) and Plus+Anaerobic (product no. 442193;
BD)) and monitored for microbial growth in the Bac-
tec™ 9240 instrument (BD). When growth was detected
by the instrument, Gram-staining was performed.
Direct inoculation
For the direct method, 5 ml of grown blood culture was
aspirated from the blood culture bottle and the aspirate
was injected in a Serum Separator Tube (SST) (BD
Diagnostic Systems, Sparks, MD, USA). This tube was
centrifuged at 2000 × g for 10 minutes, after which the
supernatant was discarded. Bacteria were harvested from
the gel layer using a sterile cotton swab and suspended
in a Phoenix system ID broth tube (product no. 246000;
BD) until a 0.5 McFarland standard suspension was
obtained. To obtain optimal results, for Gram-negative
isolates, 25 μl of this suspension were transferred into a
tube of Phoenix system AST broth (product no. 246002;
BD) in which one drop of AST indicator (product no.
246004; BD) was previously added, according to manu-
facturers’ guidelines. Since the inoculum of GPC in ID
broth was shown to be almost 10 times lower than is
standard in a 0.5 McFarland suspension, 250 μl of
inoculated ID broth was added to AST broth for GPC,
instead of the 25 μl in the manufacturers’ guidelines.
For GNR, the Phoenix system panel NMIC/ID-75 (pro-
duct no. 448087; BD) was used. For GPC, the PMIC-58
panel (product no. 448052; BD) was used.
To calculate the original number of CFU/ml in the ID
broth and to serve as purity control, dilutions of ID
broth were also subcultured, using the Eddy Jet spiral
plater (IUL, S.A., Barcelona, Spain).
Routinely used inoculation
For the routinely used method, a small volume of posi-
tive blood culture was inoculated on Columbia sheep
blood agar plates and incubated at 35°C with 5% CO2. A
standard inoculum in ID broth was prepared from the
bacteria grown on the agar medium and inoculated into
Phoenix panels, following the manufacturer’s
recommendations.
Identification of GPC
Since the Phoenix system is not used for ID of GPC in
routine diagnostics, ID by direct inoculation was not
tested in this group. To discern Staphylococcus species
from other GPC, a catalase test was performed. For the
identification of Staphylococcus species, catalase-positive
strains were tested for coagulase and DNAse produc-
tion. If both tests were negative, the strain was identified
as a coagulase-negative Staphylococcus species (CoNS).
To discern Enterococcus species from other catalase-
negative GPC, bile esculin and tellur diagnostic tablets
(Rosco Diagnostica, Taastrup, Denmark) were used,
according to manufacturer’s guidelines. If both tests
were positive, the strain was identified as Enterococcus
faecalis, whereas in case of a positive bile esculin test
but a negative tellur test, an API 20 Strep test (Biomér-
ieux SA, Marcy l’Etoile, France) was performed to
further identify the strain.
Results of identification were adjusted in the Phoenix
results retrospectively for both the standard and direct
method, after which the software automatically adjusted
MIC cutoff values to those of the identified species.
Discrepancy analysis
To resolve differences in ID of GNR, the API system
was used (API 20E for Enterobacteriaceae and API
20NE for non-fermenters (Biomérieux)). In case of dis-
crepancies in AST between results of the direct method
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and the routinely used method for ceftazidime, ceftriax-
one, cefuroxime, ciprofloxacin, clindamycin, levofloxa-
cin, moxifloxacin, linezolid, penicillin, piperacillin,
piperacillin-tazobactam, and tobramycin an E-test
(Biomérieux) was performed according to manufac-
turer’s guidelines, and used as gold standard [20,21].
Discrepancies for amoxicillin, amoxicillin-clavulanate,
erythromycin, gentamicin, oxacillin, rifampin, tetracy-
cline and trimethoprim-sulfamethoxazole were resolved
using microbroth dilution, as described in the CLSI-
guidelines [22].
Data analysis
Results of AST with the direct method (susceptible,
intermediate or resistant) were analysed for categorical
agreement with the results of the standard method.
Also, minor errors (any false result involving an inter-
mediate result), major errors (false-resistant results) and
very major errors (false-susceptible results) were
calculated.
Statistical analysis
Bacterial load in ID broth for GPC and GNR was com-
pared using an independent samples t-test.
Results
Inoculum of bacteria in ID broth after use of serum
separator tubes (SSTs)
In total, 134 blood cultures were included, from 116
patients. The inoculum of GPC in ID broth was on
average 3.6 × 107 CFU/ml, whereas that of GNR was
1.8 × 108 CFU/ml, which was a significant difference
(95% CI between -1.7 × 108 and -1.2 × 108; P < 0.001).
ID of GNR with the direct Phoenix method
ID with direct inoculation was correct for 95.2% of all
tested Enterobacteriaceae. One Escherichia coli strain
was incorrectly identified as Salmonella choleraesuis
with the direct method. One Serratia marcescens strain
could not be identified with the direct method. Identifi-
cation for Pseudomonas spp. was correct in 71.4%. Both
errors in this group involved strains of Pseudomonas
aeruginosa that were incorrectly identified as Pseudomo-
nas fluorescens (Table 1). No errors in ID were observed
for the routine method.
Antibiotic susceptibility testing (AST) of GNR
Results of AST were available for 49 strains, one P. aer-
uginosa strain failed to grow sufficiently in the Phoenix
system so no results were available for the direct
method. Categorical agreement of the direct method
with results of the standard method for GNR was 97.6%.
After discrepancy analysis of the results of AST, this
percentage rose to 99.0%, with 5 minor errors (0.7%), no
major errors, and 2 very major errors (0.3%) (Table 2).
Both very major errors occurred with trimethoprim-sul-
famethoxazole in Pseudomonas aeruginosa strains. Cate-
gorical agreement of the standard method after
discrepancy analysis was 98.4% (table 2). One very
major error occurred with trimethoprim-sulfamethoxa-
zole. No antibiotic showed a categorical agreement of
<95% (Table 3).
AST of GPC
AST using the direct method was performed for 84
GPC (22 Staphylococcus aureus, 59 CoNS, 2 Enterococ-
cus faecalis and 1 Enterococcus faecium). Categorical
agreement for the tested GPC was 93.1% compared with
results of the standard method. After discrepancy analy-
sis this was 95.4%, with a minor error rate of 1.1%, a
major error rate of 3.1% and a very major error rate of
0.4% (Table 2). Except for erythromycin and trimetho-
prim-sulfamethoxazole, all antibiotics showed a categori-
cal agreement of the direct method of >90% (table 4).
Again, all very major errors (n = 4) occurred with tri-
methoprim-sulfamethoxazole, all in CoNS strains. The
major errors were divided as follows: 10 for S. aureus,
23 for CoNS and 1 for Enterococcus spp..
Categorical agreement for the standard method after
discrepancy analysis was 97.3% (see table 2). One very
major error occurred for amoxicillin-clavulanate, 1 for
ampicillin, 1 for erythromycin, 4 for gentamicin, 1 for
moxifloxacin, 2 for oxacillin, 1 for tetracycline and 3 for
trimethoprim-sulfamethoxazole (Table 4).
Discussion
This study shows SSTs can be used to inoculate Phoenix
ID broth to a 0.5 McFarland standard, as was also
shown by Funke et al. for GNR [18]. However, a 0.5
McFarland standard for GPC obtained by using SSTs
was shown to consistently contain a lower inoculum
than 1.5 × 108 CFU/ml. This may be due to the pre-
sence of blood culture components other than bacteria,
since they could also contribute to the turbidity in the
ID broth.
This study shows very good results for ID of Entero-
bacteriaceae. Only two errors occurred with ID in this
group. One strain was not identified and one strain of E.
coli was misidentified as S. choleraesuis. Results of ID
for Pseudomonas species were less reliable. Both errors
in this group were P. aeruginosa strains that were iden-
tified as P. fluorescens, a rare cause of bloodstream
infections. These misidentifications did not lead to
errors in interpretation of AST, but rare or unlikely
results of ID should be dealt with carefully and be con-
firmed using additional tests. Other studies also showed
that ID of non-fermenting GNR was less reliable than
that of Enterobacteriaceae [18,23]. This may be due to
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the lower growth rate of non-fermenters, which could
result in weaker fluorescent biochemical reactions in the
Phoenix ID panel. Errors in ID with the direct method
could also be caused by traces of blood culture compo-
nents in the ID broth. This however seems less likely,
since with Enterobacteriaceae, errors in ID were rare.
Since the Phoenix system was not used for ID of GPC,
ID by direct inoculation was not tested in this group.
But since ID is required for interpretation of AST, in
clinical practice, rapid AST will have to be combined
with a rapid method of ID, such as PCR-based methods
on whole blood, like LightCycler® SeptiFast Test
MGRADE (Roche), VYOO Sepsis Test (SIRS-Lab), Sep-
siTest™ (Molzym), or MALDITOF-MS on positive
blood cultures [24].
Some studies on direct methods for AST showed poor
results for GPC [15,16] or focus on GNR only due to
unfavorable results for GPC [17]. However, in this
study, direct AST for Staphylococcus species and Entero-
coccus species showed good agreement with conven-
tional methods, comparable to results of the standard
method, but with fewer very major errors. Lupetti et al.
[19], who tested the direct Phoenix method for GPC
and compared their results with those of the Vitek 2,
found an even higher agreement. They incubated a por-
tion of the positive blood culture with saponin in order
to harvest more bacteria from a positive blood culture
through the release of intracellular bacteria.
Other studies that presented results of direct methods
for AST of GPC showed variable results [13-16,25,26],
which makes comparison difficult. But our results were
comparable to those of the routine Phoenix method.
Moreover, categorical agreement for most tested anti-
biotics in this study, including oxacillin and vancomycin,
were well over 90% and the percentage of major and
very major errors is low, meeting the standards pro-
posed by Jorgensen et al. [27]. Only erythromycin and
trimethoprim-sulfamethoxazole showed lower agree-
ments. The majority of errors for erythromycin were
minor errors, but also some major errors occurred. Tri-
methoprim-sulfamethoxazole was the only antibiotic for
both GPC and GNR showing very major errors. Lupetti
et al. showed a lower agreement of 94% for erythromy-
cin as well, but observed no very major errors for tri-
methoprim-sulfamethoxazole. Some other studies on
direct methods for AST showed some very major errors
for trimethoprim-sulfamethoxazole [15,16,18], but only
Kerremans et al. [13] found a very high percentages of
very major errors for this antibiotic in GPC, but not in
GNR. Therefore, we conclude that the direct Phoenix
method using SSTs can be used to reliably report results
of AST for GPC, except for trimethoprim-sulfamethoxa-
zole and erythromycin.
The direct method of AST for GNR showed very good
agreement with conventional methods for both
Table 1 Results of identification of GNR with the direct method
Total no. of strains No. of unidentified strains No. of misidentified strains ID of misidentified strains
Enterobacteriaceae
E. coli 26 1 Salmonella choleraesuis
K. pneumoniae spp. pneumoniae 8
S. marcescens 4 1
K. oxytoca 1
P. mirabilis 1
E. cloacae 1
M. morganii 1
Non-fermenters
P. aeruginosa 7 2 Pseudomonas fluorescens
Table 2 Agreements and errors for AST of GPC and GNR
for the direct and routinely used Phoenix method
Direct vs
routinely
used method
Direct method
after discrepancy
analysis
Routine method
after discrepancy
analysis
GPC
(n = 84)
Categorical
agreement
93.1% 95.4% 97.3%
Minor
errors
1.7% 1.1% 0.7%
Major
errors
4.2% 3.1% 0.8%
Very major
errors
0.9% 0.4% 1.6%
GNR
(n = 49)
Categorical
agreement
97.6% 99.0% 98.4%
Minor
errors
1.9% 0.7% 1.4%
Major
errors
0.1% 0.0% 0.1%
Very major
errors
0.4% 0.3% 0.1%
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Enterobacteriaceae and Pseudomonas species, compar-
able to the routinely used method, with essential agree-
ments and categorical agreements of over 95% for all
antibiotics tested (see table 3). Both very major errors
occurred with trimethoprim-sulfamethoxazole in Pseu-
domonas aeruginosa strains that were correctly identi-
fied. For these strains, it would never be considered an
adequate treatment, due to intrinsic resistance. These
errors thus would not have clinical consequences. Funke
et al. [18] also described a categorical agreement of
99.0%, which is comparable with or higher than results
from studies on other direct methods of AST
[7,13-16,26]. Therefore, we conclude that also for GNR,
results of the direct Phoenix method for AST can be
used to guide antibiotic therapy in bloodstream
infections.
The strains tested in this study are a representative
sample of the strains most frequently encountered in
clinical practice. A limitation of the study is the low
number of tested Enterococcus and Pseudomonas strains
(3 and 7, respectively), however, both groups show very
good agreement, with only few errors.
Inoculating ID and AST broth by using SSTs can be
performed as soon as blood culture bottles are taken
out of the BACTEC system and takes approximately 30
minutes, whereas a subculture takes up to 24 hours.
Table 3 Agreement and errors of the direct method for AST for GNR, after discrepancy analysis
Antimicrobial agent No. of tested
strains
% categorical
agreement
No. of minor errors
(%)
No. of major errors
(%)
No. of very major errors
(%)
Amikacin 49 100 0 0 0
Amoxicillin/clavulanate 49 98.0 1 (2.0) 0 0
Ampicillin 49 98.0 1 (2.0) 0 0
Ceftazidime 49 100 0 0 0
Ceftriaxone 49 98.0 1 (2.0) 0 0
Cefuroxime 49 98.0 1 (2.0) 0 0
Ciprofloxacin 49 100 0 0 0
Colistin 49 100 0 0 0
Gentamicin 49 100 0 0 0
Levofloxacin 49 100 0 0 0
Meropenem 49 100 0 0 0
Piperacillin 49 98.0 1 (2.0) 0 0
Piperacillin/tazobactam 49 100 0 0 0
Tobramycin 49 100 0 0 0
Trimethoprim/
sulfamethoxazole
49 96.0 0 0 2 (4.0)
Total 735 99.0 5 (0.7) 0 (0) 2 (0.3)
Table 4 Agreement and errors of the direct method of AST for GPC after discrepancy analysis
Antimicrobial agent No. of tested
strains
% categorical
agreement
No. of minor errors
(%)
No. of major errors
(%)
No. of very major errors
(%)
Amoxicillin/clavulanate 84 91.7 0.0 7 (8.3) 0
Ampicillin 84 94 0 5 (6.0) 0
Clindamycin 84 96.4 2 (2.4) 1 (1.2) 0
Erythromycin 84 86.9 8 (9.5) 2 (3.6) 0
Gentamicin 84 100 0 0 0
Linezolid 84 91.6 1 (1.2) 6 (7.2) 0
Moxifloxacin 84 100 0 0 0
Oxacillin 84 96.4 0 3 (3.6) 0
Penicillin 84 98.8 0 1 (1.2) 0
Rifampin 82 98.8 0 1 (1.2) 0
Tetracycline 84 97.6 1 (1.2) 1 (1.2) 0
Trimethoprim/
Sulfamethoxazole
84 89.2 0 5 (6.0) 4 (4.8)
Vancomycin 84 98.8 0 1 (1.2) 0
Total 1090 95.4 12 (1.1) 34 (3.1) 4 (0.4)
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Therefore, by using the direct method, results of ID and
AST can be available up to 23.5 hours earlier than with
the routinely used method.
Conclusions
From these results we conclude that AST by inoculating
Phoenix panels with bacteria harvested directly from
positive blood culture bottles is as reliable as using bac-
teria from a subculture on agar, with the exception of
results for erythromycin and trimethoprim-sulfamethox-
azole in Staphylococcus and Enterococcus spp., which
should not be reported due to their low agreement.
Results of ID of Enterobacteriaceae were shown to be
very reliable. ID of Staphylococcus and Enterococcus spp.
was not performed with the direct method. Caution is
warranted about interpretation of results of Enterococcus
and Pseudomonas spp., of which only a limited number
of strains was tested.
Thus, by only a small change in daily laboratory rou-
tine, results of ID and AST of positive blood culture iso-
lates can be obtained up to a day earlier than with the
standard method, thereby leading to earlier targeting of
antibiotic therapy in patients with bloodstream
infections.
Acknowledgements
This work was supported by Profileringsfonds azM (PF245). The
Profileringsfonds azM had no role in the study design, in the collection or
analysis of data, or in the writing or submission of the manuscript.
Author details
1Department of Medical Microbiology, Care And Public Health Research
Institute (CAPHRI), Maastricht University Medical Center, PO Box 5800,
6202AZ, Maastricht, the Netherlands. 2Department of Internal Medicine,
Erasmus University Medical Center, PO Box 2040, 3000CA, Rotterdam, the
Netherlands.
Authors’ contributions
JB: conceived of the study, performed the gold standard tests and statistical
analysis, and drafted the manuscript. CFMD: carried out the direct Phoenix
method, performed the analysis and helped to draft the manuscript. CFML:
participated in the design of the study and helped to draft the manuscript.
PFGW: participated in the design of the study and helped to draft the
manuscript. AV: conceived of the study, coordinated it, and helped to draft
the manuscript.
All authors read and approved the final manuscript.
Received: 14 January 2011 Accepted: 30 June 2011
Published: 30 June 2011
References
1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR:
Epidemiology of severe sepsis in the United States: analysis of
incidence, outcome, and associated costs of care. Critical care medicine
2001, 29(7):1303-1310.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Facing the challenge:
decreasing case fatality rates in severe sepsis despite increasing
hospitalizations. Critical care medicine 2005, 33(11):2555-2562.
3. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in
the United States from 1979 through 2000. The New England journal of
medicine 2003, 348(16):1546-1554.
4. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R,
Carlet J, Le Gall JR, Payen D: Sepsis in European intensive care units:
results of the SOAP study. Critical care medicine 2006, 34(2):344-353.
5. Bearman GM, Wenzel RP: Bacteremias: a leading cause of death. Archives
of medical research 2005, 36(6):646-659.
6. Barenfanger J, Drake C, Kacich G: Clinical and financial benefits of rapid
bacterial identification and antimicrobial susceptibility testing. Journal of
clinical microbiology 1999, 37(5):1415-1418.
7. Bruins M, Oord H, Bloembergen P, Wolfhagen M, Casparie A, Degener J,
Ruijs G: Lack of effect of shorter turnaround time of microbiological
procedures on clinical outcomes: a randomised controlled trial among
hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis
2005, 24(5):305-313.
8. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W,
Verbrugh HA, Vos MC: Rapid identification and antimicrobial
susceptibility testing reduce antibiotic use and accelerate pathogen-
directed antibiotic use. The Journal of antimicrobial chemotherapy 2008,
61(2):428-435.
9. Doern GV, Vautour R, Gaudet M, Levy B: Clinical impact of rapid in vitro
susceptibility testing and bacterial identification. Journal of clinical
microbiology 1994, 32(7):1757-1762.
10. Fraser A, Paul M, Almanasreh N, Tacconelli E, Frank U, Cauda R, Borok S,
Cohen M, Andreassen S, Nielsen AD, et al: Benefit of appropriate empirical
antibiotic treatment: thirty-day mortality and duration of hospital stay.
The American journal of medicine 2006, 119(11):970-976.
11. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of
inadequate antimicrobial treatment of bloodstream infections on
patient outcomes in the ICU setting. Chest 2000, 118(1):146-155.
12. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R,
Feinstein D, Zanotti S, Taiberg L, et al: Duration of hypotension before
initiation of effective antimicrobial therapy is the critical determinant of
survival in human septic shock. Critical care medicine 2006,
34(6):1589-1596.
13. Kerremans JJ, Goessens WH, Verbrugh HA, Vos MC: Accuracy of
identification and susceptibility results by direct inoculation of Vitek 2
cards from positive BACTEC cultures. Eur J Clin Microbiol Infect Dis 2004,
23(12):892-898.
14. Chapin KC, Musgnug MC: Direct susceptibility testing of positive blood
cultures by using Sensititre broth microdilution plates. Journal of clinical
microbiology 2003, 41(10):4751-4754.
15. Waites KB, Brookings ES, Moser SA, Zimmer BL: Direct susceptibility testing
with positive BacT/Alert blood cultures by using MicroScan overnight
and rapid panels. Journal of clinical microbiology 1998, 36(7):2052-2056.
16. de Cueto M, Ceballos E, Martinez-Martinez L, Perea EJ, Pascual A: Use of
positive blood cultures for direct identification and susceptibility testing
with the vitek 2 system. Journal of clinical microbiology 2004, 42(8):3734-3738.
17. Bruins MJ, Bloembergen P, Ruijs GJ, Wolfhagen MJ: Identification and
susceptibility testing of Enterobacteriaceae and Pseudomonas
aeruginosa by direct inoculation from positive BACTEC blood culture
bottles into Vitek 2. Journal of clinical microbiology 2004, 42(1):7-11.
18. Funke G, Funke-Kissling P: Use of the BD PHOENIX Automated
Microbiology System for direct identification and susceptibility testing of
gram-negative rods from positive blood cultures in a three-phase trial.
Journal of clinical microbiology 2004, 42(4):1466-1470.
19. Lupetti A, Barnini S, Castagna B, Nibbering PH, Campa M: Rapid
identification and antimicrobial susceptibility testing of Gram-positive
cocci in blood cultures by direct inoculation into the BD Phoenix
system. Clin Microbiol Infect 2010, 16(7):986-991.
20. Baker CN, Stocker SA, Culver DH, Thornsberry C: Comparison of the E Test
to agar dilution, broth microdilution, and agar diffusion susceptibility
testing techniques by using a special challenge set of bacteria. Journal
of clinical microbiology 1991, 29(3):533-538.
21. Brown DF: The E-Test challenged with selected strains. Diagnostic
microbiology and infectious disease 1992, 15(5):465-468.
22. CLSI: Performance Standards for Antimicrobial Susceptiblity Testing;
Seventeenth Informational Supplement. CLSI Document M100-17.
Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite
1400, Wayne, Pennsylvania, 19087-1898, USA; 200727.
23. Ling TK, Liu ZK, Cheng AF: Evaluation of the VITEK 2 system for rapid
direct identification and susceptibility testing of gram-negative bacilli
Beuving et al. BMC Microbiology 2011, 11:156
http://www.biomedcentral.com/1471-2180/11/156
Page 6 of 7
from positive blood cultures. Journal of clinical microbiology 2003,
41(10):4705-4707.
24. La Scola B, Raoult D: Direct identification of bacteria in positive blood
culture bottles by matrix-assisted laser desorption ionisation time-of-
flight mass spectrometry. PloS one 2009, 4(11):e8041.
25. Diederen BM, Zieltjens M, Wetten H, Buiting AG: Identification and
susceptibility testing of Staphylococcus aureus by direct inoculation
from positive BACTEC blood culture bottles. Clin Microbiol Infect 2006,
12(1):84-86.
26. Wellinghausen N, Pietzcker T, Poppert S, Belak S, Fieser N, Bartel M, Essig A:
Evaluation of the Merlin MICRONAUT system for rapid direct
susceptibility testing of gram-positive cocci and gram-negative bacilli
from positive blood cultures. Journal of clinical microbiology 2007,
45(3):789-795.
27. Jorgensen JH: Selection criteria for an antimicrobial susceptibility testing
system. Journal of clinical microbiology 1993, 31(11):2841-2844.
doi:10.1186/1471-2180-11-156
Cite this article as: Beuving et al.: Evaluation of direct inoculation of the
BD PHOENIX system from positive BACTEC blood cultures for both
Gram-positive cocci and Gram-negative rods. BMC Microbiology 2011
11:156.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Beuving et al. BMC Microbiology 2011, 11:156
http://www.biomedcentral.com/1471-2180/11/156
Page 7 of 7
